Stereotaxis, Inc. (STXS)
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Instruments & Supplies
Stereotaxis, Inc.
NYSE:STXSHealthcare · Medical - Equipment & Services
+2.20%$1.02
AH Close$1.02+0.00%vs close
AH Close$1.02+0.00%vs close
Mkt Cap$102.21M
Float80.94M
O/S100.2M
Inst Own41.3%
SI7.0%
Dilution
MCap$102.21M
Float80.94M
O/S100.2M
Dilution